(RTTNews) - Novavax (NVAX) has filed for authorization with Health Canada for 2024-2025 Formula COVID-19 vaccine or NVX-CoV2705 for individuals aged 12 and older. Novavax plans to have its vaccine ...

Novavax's (NVAX) updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- ...

GAITHERSBURG, Md., Nov. 18, 2022 /PRNewswire/ -- Novavax, Inc. (NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, ...

Dec 5 (Reuters) - Novavax (NVAX.O), opens new tab said on Tuesday that Health Canada had authorized its updated COVID-19 vaccine, targeting the Omicron subvariant XBB.1.5, in individuals aged 12 years ...

Fall is here, which means respiratory viruses like flu, RSV and COVID are expected to keep spreading as weather cools and more people gather indoors. Luckily, we've got vaccines in stock to help ...

Novavax shares currently trade at an extremely modest price-to-sales ratio. The company has previously raised concerns about its ability to survive as a business. Demand for COVID shots has been low, ...

GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M ™ adjuvant, today announced that Health Canada has ...

Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer. Jessica was a writer on the Wellness team, with a focus on health ...